Bare Anatomy: Financial Breakdown
Decoding financial health metrics of Bare Anatomy
Total Revenue₹39.4 Cr+226%Prev. FY
Total Expenses₹56.0 Cr+162%Prev. FY
Profit After Tax₹-16.6 Cr+-55%Prev. FY
Total Assets₹36.3 Cr+195%Prev. FY
Net Profit Margin-0.4%52%Prev. FY
FAQs on Financials of Bare Anatomy
No. In FY23, Bare Anatomy reported a net loss of ₹16.6 Cr+, so it was not profitable.
Bare Anatomy's revenue grew 226.0% year-on-year, from ₹12.1 Cr+ in FY22 to ₹39.4 Cr+ in FY23.
Bare Anatomy's estimated EBITDA for FY23 was ₹-15.7 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY23, Bare Anatomy posted revenue of ₹39.4 Cr+ (up 226.0% YoY) and a net loss of ₹16.6 Cr+. Explore the full financials of Bare Anatomy here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links